Incyte Corporation
INCY
$99.13
-$1.19-1.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.36B | 5.14B | 4.81B | 4.58B | 4.41B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.36B | 5.14B | 4.81B | 4.58B | 4.41B |
| Cost of Revenue | 2.53B | 2.42B | 2.26B | 2.31B | 2.94B |
| Gross Profit | 2.83B | 2.72B | 2.56B | 2.28B | 1.47B |
| SG&A Expenses | 1.37B | 1.37B | 1.33B | 1.31B | 1.26B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.91B | 3.79B | 3.58B | 3.62B | 4.20B |
| Operating Income | 1.45B | 1.35B | 1.23B | 966.47M | 209.72M |
| Income Before Tax | 1.77B | 1.66B | 1.59B | 1.26B | 314.66M |
| Income Tax Expenses | 342.08M | 377.80M | 399.65M | 391.58M | 293.39M |
| Earnings from Continuing Operations | 1.43K | 1.29K | 1.19K | 870.87 | 21.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.43B | 1.29B | 1.19B | 870.87M | 21.27M |
| EBIT | 1.45B | 1.35B | 1.23B | 966.47M | 209.72M |
| EBITDA | 1.55B | 1.44B | 1.32B | 1.06B | 299.38M |
| EPS Basic | 7.29 | 6.59 | 6.11 | 4.50 | 0.37 |
| Normalized Basic EPS | 5.04 | 4.70 | 4.31 | 3.46 | 1.22 |
| EPS Diluted | 7.08 | 6.41 | 5.97 | 4.40 | 0.32 |
| Normalized Diluted EPS | 4.88 | 4.57 | 4.20 | 3.39 | 1.17 |
| Average Basic Shares Outstanding | 786.45M | 780.82M | 776.53M | 773.49M | 797.67M |
| Average Diluted Shares Outstanding | 811.77M | 803.14M | 795.79M | 790.20M | 809.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |